Top Markets
Coin of the day
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Rang în acțiuni #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Preț acțiune
$0.12164306
Ultima sincronizare: 2024-11-11
Capitalizare de piață
$38.53M
Schimbare (1 zi)
-4.14%
Schimbare (1 an)
0.00%
Țară
AU
Tranzacționează PharmAust Limited (PAA)

Categorie

EPS pentru PharmAust Limited (PAA)
EPS la data de June 2024 TTM: $-0.01
Conform celor mai recente rapoarte financiare și prețului acțiunilor PharmAust Limited, EPS-ul actual al companiei (TTM) este $-0.01. La sfârșitul anului 2023, compania avea un EPS de $-0.01 o scădere comparativ cu EPS-ului din 2022, care a fost de $0.00.
Istoricul EPS pentru PharmAust Limited din 2001 până în 2026
EPS la sfârșitul fiecărui an
An EPS Schimbă
2026 (TTM) $-0.01 -41.50%
2024 $-0.02 26.36%
2023 $-0.01 248.65%
2022 0.00 19.35%
2021 0.00 -3.13%
2020 0.00 -36.00%
2019 $-0.01 -60.63%
2018 $-0.01 53.01%
2017 $-0.01 -73.82%
2016 $-0.03 61.73%
2015 $-0.02 4.81%
2014 $-0.02 23.03%
2013 $-0.02 -90.70%
2012 $-0.16 -57.64%
2011 $-0.39 1,413.73%
2010 $-0.03 142.86%
2009 $-0.01 -97.72%
2008 $-0.46 -48.36%
2007 $-0.89 96.82%
2006 $-0.45 -40.46%
2005 $-0.76 -18.86%
2004 $-0.94 -11.50%
2003 $-1.06 -45.34%
2002 $-1.94 47.75%
2001 $-1.31 0.00%
EPS pentru companii similare sau concurente
Companie EPS Diferență EPS Țara
$17.32 -148,134.19%
US
$27.74 -237,194.02%
NL
$2.98 -25,570.09%
AU
$-7.98 68,105.13%
US
- -
CH